As Senior Associate, Mr. DiNoto joined the NovaQuest Capital Product Finance team in 2019. He is responsible for financial modeling, investment due diligence and transaction structuring.
Prior to joining NovaQuest Capital, Mr. DiNoto was a vice president at Greenhill & Co. where he focused on mergers and acquisitions, strategic advisory and corporate finance transactions across the healthcare industry. Prior to that, Mr. DiNoto was an associate at Wells Fargo Securities where he executed mergers and acquisitions, debt and equity transactions for healthcare companies.
Earlier in his career, Mr. DiNoto worked in corporate development at Eli Lilly & Co. and Vascular Pharmaceuticals and in healthcare management consulting at PricewaterhouseCoopers.